Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	-46.71	-20178.24	-13753.55
Graham Fair Price	inf	0.00	< 0.005
PEG	inf	0.00	0.08
Price/Book	671.84	1140783.45	147801.21
Price/Cash Flow	-100.00	-16.46	0.00
Prices/Earnings	inf	0.00	-3438.39
Price/Sales	100.00	12758.77	0.00
Price/FCF	-100.00	-16.46	0.00
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	100.00	0.52	0.00
Operating Margin	-100.00	-701.40	0.00
ROA	inf	0.00	-0.11
ROE	-10.75	0.00	inf
ROIC	-0.11	n.A.	n.A.
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	0.00	-1.00	inf
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-336.94	0.00	inf
EPS QOQ	-414.53	0.00	inf
FCF QOQ	0.00	0.00	0.00
Revenue QOQ	0.00	0.00	0.00
Naive Interpretation	member

03 - Financial Growth · Not Interpreted

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.05	100.00
Days Sales Outstanding (DSO)	0.00	0.06	100.00
Inventory Turnover	0.00	1868.91	100.00
Debt/Capitalization	0.00	0.12	100.00
Quick Ratio	0.00	6.35	100.00
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	< 0.005	< 0.005	-86.75
Cash	< 0.005	< 0.005	-99.85
Capex	n.A.	-0.02	n.A.
Free Cash Flow	n.A.	-0.71	n.A.
Revenue	0.00	< 0.005	100.00
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	0.00	6.64	100.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	0.01	0.02	23.73
Naive Interpretation	Member

06 - Financial Health · Bad

Rating